0.0330
+0.0010
+(3.12%)
At close: 3:58:50 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
5,091.0000
5,091.0000
8,429.0000
1,719.0000
1,337.0000
Cost of Revenue
3,957.0000
3,957.0000
558.0000
--
--
Gross Profit
1,134.0000
1,134.0000
7,871.0000
1,719.0000
1,337.0000
Operating Expense
9,709.0000
9,709.0000
11,261.0000
14,685.0000
17,588.0000
Operating Income
-8,575.0000
-8,575.0000
-3,390.0000
-12,966.0000
-16,251.0000
Net Non Operating Interest Income Expense
134.0000
134.0000
122.0000
18.0000
34.0000
Other Income Expense
2,873.0000
2,873.0000
3,056.0000
3,366.0000
3,785.0000
Pretax Income
-5,568.0000
-5,568.0000
-212.0000
-9,582.0000
-12,432.0000
Tax Provision
232.0000
232.0000
552.0000
252.0000
197.0000
Net Income Common Stockholders
-5,800.0000
-5,800.0000
-764.0000
-9,834.0000
-12,629.0000
Basic EPS
-0.00
-0.02
-0.00
-0.03
-0.06
Diluted EPS
-0.00
-0.02
-0.00
-0.03
-0.06
Basic Average Shares
287,862.8360
289,499.9990
286,461.0990
283,881.6130
219,726.0770
Diluted Average Shares
287,862.8360
289,499.9990
286,461.0990
283,881.6130
219,726.0770
Net Income from Continuing & Discontinued Operation
-5,800.0000
-5,800.0000
-764.0000
-9,834.0000
-12,629.0000
Normalized Income
-5,800.0000
-5,800.0000
-539.3000
-9,834.0000
-12,629.0000
Interest Income
134.0000
134.0000
122.0000
18.0000
34.0000
Net Interest Income
134.0000
134.0000
122.0000
18.0000
34.0000
EBIT
-8,575.0000
-8,575.0000
-3,390.0000
-12,966.0000
-16,251.0000
EBITDA
-8,065.0000
-8,065.0000
-2,795.0000
-12,306.0000
-15,586.0000
Reconciled Cost of Revenue
3,957.0000
3,957.0000
558.0000
--
--
Reconciled Depreciation
510.0000
510.0000
595.0000
660.0000
665.0000
Net Income from Continuing Operation Net Minority Interest
-5,800.0000
-5,800.0000
-764.0000
-9,834.0000
-12,629.0000
Total Unusual Items Excluding Goodwill
--
--
-321.0000
--
--
Total Unusual Items
--
--
-321.0000
--
--
Normalized EBITDA
-8,065.0000
-8,065.0000
-2,474.0000
-12,306.0000
-15,586.0000
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
--
--
-96.3000
--
--
6/30/2021 - 9/28/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1AI.AX Algorae Pharmaceuticals Limited
0.0060
-14.29%
1AD.AX AdAlta Limited
0.0170
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0510
+6.25%
ADO.AX AnteoTech Limited
0.0180
0.00%
AGN.AX Argenica Therapeutics Limited
0.6950
+6.11%
CMB.AX Cambium Bio Limited
0.3900
0.00%
BTC.AX BTC Health Limited
0.0550
-8.33%
AVE.AX Avecho Biotechnology Limited
0.0040
+33.33%
ACW.AX Actinogen Medical Limited
0.0270
0.00%
BIT.AX Biotron Limited
0.0160
0.00%